AREV Life Sciences Global Corp.
AREVF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -80.7% | 33.8% | -2.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 59.3% | 72.6% | 100% | 66.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,668.7% | -312.8% | -262.3% | -1,568.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,940.4% | -388.4% | -550.4% | -1,640% |
| EPS Diluted | -0.048 | -0.05 | -0.068 | -0.36 |
| % Growth | 4% | 26.8% | 81% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |